series-a
Stage
1
Investors
About
Scenic Biotech develops disease-modifying therapies by discovering modifier genes that can neutralize the impact of genetic disorders, focusing on neuro- and metabolic diseases.
Explore Scenic Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.